|
C17ORF65 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.413800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.533200E-01 |
| Normal-vs-Stage2 |
2.416600E-01 |
| Normal-vs-Stage3 |
2.234600E-01 |
| Normal-vs-Stage4 |
9.786600E-01 |
| Stage1-vs-Stage2 |
1.177000E-01 |
| Stage1-vs-Stage3 |
2.119600E-01 |
| Stage1-vs-Stage4 |
9.171600E-01 |
| Stage2-vs-Stage3 |
4.415800E-02 |
| Stage2-vs-Stage4 |
3.155800E-01 |
| Stage3-vs-Stage4 |
3.599000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.640600E-01 |
| Normal-vs-AfricanAmerican |
8.230300E-02 |
| Normal-vs-Asian |
9.360000E-01 |
| Caucasian-vs-AfricanAmerican |
1.668100E-02 |
| Caucasian-vs-Asian |
6.158400E-01 |
| AfricanAmerican-vs-Asian |
1.078410E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.229800E-01 |
| Normal-vs-Female |
7.607000E-01 |
| Male-vs-Female |
6.595800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.021600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.849200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.728000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.814000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.537400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.363200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.741000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.709000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.838000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.985200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.05770000219985E-08 |
| Classical-VS-Follicular |
6.870000E-02 |
| Classical-VS-Other |
7.101000E-01 |
| Classical-VS-Normal |
9.394200E-01 |
| Tall-VS-Follicular |
2.10980000137084E-08 |
| Tall-VS-Other |
4.138300E-02 |
| Tall-VS-Normal |
1.75805999999001E-05 |
| Follicular-VS-Other |
8.244200E-01 |
| Follicular-VS-Normal |
1.610030E-01 |
| Other-VS-Normal |
6.570600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.191800E-01 |
| Normal-vs-N1 |
3.925400E-01 |
| N0-vs-N1 |
7.864400E-02 |
|
|
